nach oben

Endocrine Pathology

Erschienen in:

01.09.2012

Water-Clear Parathyroid Adenoma: Report of Two Cases and Literature Review

verfasst von: Shuting Bai, Virginia A. LiVolsi, Douglas L. Fraker, Zhanyong Bing

Erschienen in: Endocrine Pathology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Excerpt

Water-clear cell parathyroid adenoma is very rare. Based on our institution database of parathyroid adenoma in 2010 and 2011, water-clear cell parathyroid adenoma is about 0.4 % of parathyroid adenomas in this period. Only ten cases have been reported in English literature [1‐10]. Water-clear cell adenoma consists of large polygonal cells with abundant clear cell cytoplasm; most of the patients presented as primary hyperparathyroidism. Water-clear cell adenoma can morphologically mimic numerous tumors composed of clear cells, especially metastatic clear cell renal cell carcinoma. We reported here additional two cases of water-clear cell adenoma with review of the literature. …

Begueret H, Belleannee G, Dubrez J, Trouette H, Parrens M, Velly JF, de Mascarel A: Clear cell adenoma of the parathyroid gland: a rare and misleading lesion, Ann Pathol 1999, 19:316–319PubMed

Dundar E, Grenko RT, Akalin A, Karahuseyinoglu E, Bildirici K: Intrathyroidal water-clear cell parathyroid adenoma: a case report, Hum Pathol 2001, 32:889–892PubMedCrossRef

Grenko RT, Anderson KM, Kauffman G, Abt AB: Water-clear cell adenoma of the parathyroid. A case report with immunohistochemistry and electron microscopy, Arch Pathol Lab Med 1995, 119:1072–1074PubMed

Kanda K, Okada Y, Tanikawa T, Morita E, Tsurudome Y, Konishi T, Tanaka Y: A rare case of primary hyperparathyroidism with clear cell adenoma, Endocr J 2004, 51:207–212PubMedCrossRef

Kodama H, Iihara M, Okamoto T, Obara T: Water-clear cell parathyroid adenoma causing primary hyperparathyroidism in a patient with neurofibromatosis type 1: report of a case, Surg Today 2007, 37:884–887PubMedCrossRef

Kovacs K, Horvath E, Ozawa Y, Yamada S, Matushita H: Large clear cell adenoma of the parathyroid in a patient with MEN-1 syndrome. Ultrastructural study of the tumour exhibiting unusual RER formations, Acta Biol Hung 1994, 45:275–284PubMed

Kuhel WI, Gonzales D, Hoda SA, Pan L, Chiu A, Giri D, DeLellis RA: Synchronous water-clear cell double parathyroid adenomas a hitherto uncharacterized entity?, Arch Pathol Lab Med 2001, 125:256–259PubMed

Prasad KK, Agarwal G, Krishnani N: Water-clear cell adenoma of the parathyroid gland: a rare entity, Indian J Pathol Microbiol 2004, 47:39–40PubMed

Liang Y, Mojica W, Chen F: Water-clear cell adenoma of parathyroid gland: a case report and literature review, N A J Med Sci. 2010, 3(4):194–198

10.

Papanicolau-Sengos A, Brumund K, Lin G, Hasteh F: Cytologic findings of a clear cell parathyroid lesion, Diagn Cytopathol. 2011, doi:10.1002/dc.22806

11.

Carlson D: Parathyroid pathology: hyperparathyroidism and parathyroid tumors, Arch Pathol Lab Med 2010, 134:1639–1644PubMed

12.

Roth SI: The ultrastructure of primary water-clear cell hyperplasia of the parathyroid glands, Am J Pathol 1970, 61:233–248PubMed

13.

Sheldon H: On the Water-Clear Cell in the Human Parathyroid Gland, J Ultrastruct Res 1964, 10:377–383PubMedCrossRef

14.

Emura S, Shoumura S, Utsumi M, Yamahira T, Chen H, Arakawa M, Isono H: Origin of the water-clear cell in the parathyroid gland of the golden hamster, Acta Anat (Basel) 1991, 140:357–361CrossRef

15.

Emura S, Shoumura S, Isono H: Ultrastructure of the water-clear cell in the rabbit parathyroid gland, Arch Histol Cytol 1992, 55:159–166PubMedCrossRef

16.

Haynes JI: Parathyroid morphology of the brush-tail possum, Trichosurus vulpecula, Anat Rec 1995, 241:401–410PubMedCrossRef

17.

Haynes JI: Parathyroids and ultimobranchial bodies in monotremes, Anat Rec 1999, 254:269–280PubMedCrossRef

18.

Zhang C, Kong D, Tan MH, Pappas DL, Jr., Wang PF, Chen J, Farber L, Zhang N, Koo HM, Weinreich M, Williams BO, Teh BT: Parafibromin inhibits cancer cell growth and causes G1 phase arrest, Biochem Biophys Res Commun 2006, 350:17–24PubMedCrossRef

19.

Wild P, Setoguti T: Mammalian parathyroids: morphological and functional implications, Microsc Res Tech 1995, 32:120–128PubMedCrossRef

20.

Cinti S, Sbarbati A: Ultrastructure of human parathyroid cells in health and disease, Microsc Res Tech 1995, 32:164–179PubMedCrossRef

21.

Sourbier C, Massfelder T: Parathyroid hormone-related protein in human renal cell carcinoma, Cancer Lett 2006, 240:170–182PubMedCrossRef

22.

Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA: Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone, J Clin Invest 1987, 80:1803–1807PubMedCrossRef

23.

McGregor DK, Khurana KK, Cao C, Tsao CC, Ayala G, Krishnan B, Ro JY, Lechago J, Truong LD: Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody ‘Renal Cell Carcinoma Marker’, Am J Surg Pathol 2001, 25:1485–1492PubMedCrossRef

24.

Gokden N, Gokden M, Phan DC, McKenney JK: The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker, Am J Surg Pathol 2008, 32:1462–1467PubMedCrossRef

25.

Ozcan A, Zhai J, Hamilton C, Shen SS, Ro JY, Krishnan B, Truong LD: PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin, Am J Clin Pathol 2009, 131:393–404PubMedCrossRef

26.

Ozcan A, Zhai Q, Javed R, Shen SS, Coffey D, Krishnan B, Truong LD: PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin, Arch Pathol Lab Med 2010, 134:1121–1129PubMed

27.

Truong LD, Shen SS: Immunohistochemical diagnosis of renal neoplasms, Arch Pathol Lab Med 2011, 135:92–109PubMed

28.

Zhai QJ, Ozcan A, Hamilton C, Shen SS, Coffey D, Krishnan B, Truong LD: PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: a comprehensive immunohistochemical study, Appl Immunohistochem Mol Morphol 2010, 18:323–332PubMedCrossRef

29.

Davies JA, Perera AD, Walker CL: Mechanisms of epithelial development and neoplasia in the metanephric kidney, Int J Dev Biol 1999, 43:473–478PubMed

30.

Dressler GR: Pax-2, kidney development, and oncogenesis, Med Pediatr Oncol 1996, 27:440–444PubMedCrossRef

31.

Rothenpieler UW, Dressler GR: Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development, Development 1993, 119:711–720PubMed

32.

Torres M, Gomez-Pardo E, Dressler GR, Gruss P: Pax-2 controls multiple steps of urogenital development, Development 1995, 121:4057–4065PubMed

33.

Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT: HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours, J Med Genet 2003, 40:657–663PubMedCrossRef

34.

Newey PJ, Bowl MR, Cranston T, Thakker RV: Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors, Hum Mutat 2010, 31:295–307PubMedCrossRef

35.

Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, Marsh DJ: Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias, Am J Surg Pathol 2006, 30:1140–1149PubMed

36.

Witteveen JE, Hamdy NA, Dekkers OM, Kievit J, van Wezel T, Teh BT, Romijn JA, Morreau H: Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma, Mod Pathol 2010, 24:688–697CrossRef

37.

Zheng HC, Wei ZL, Xu XY, Nie XC, Yang X, Takahashi H, Takano Y: Parafibromin expression is an independent prognostic factor for colorectal carcinomas, Hum Pathol 2010, 42:1089–1102CrossRef

38.

Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, Takano Y: Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas, Virchows Arch 2008, 452:147–155PubMedCrossRef

39.

Albiges L, Couturier J, Allory Y, Camparo P, Sibony M, Vieillefond A, The BT, Escudier BJ, Molinie V. Parafibromin as a new immunohistochemistry staining to improve pathologic diagnosis of renal oncocytoma: analysis of 225 renal tumors. J Clin Oncol 29: 2011 (suppl 7; abstr 408)

Titel: Water-Clear Parathyroid Adenoma: Report of Two Cases and Literature Review
verfasst von: Shuting Bai
Virginia A. LiVolsi
Douglas L. Fraker
Zhanyong Bing
Publikationsdatum: 01.09.2012
Verlag: Springer US
Erschienen in: Endocrine Pathology / Ausgabe 3/2012
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI: https://doi.org/10.1007/s12022-012-9211-1

Springer Medizin

Water-Clear Parathyroid Adenoma: Report of Two Cases and Literature Review

Excerpt

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Unusual Type of Growth Hormone-Producing Pituitary Tumor in Acromegaly

Increasing Diagnosis of Thyroid Papillary Carcinoma Follicular Variant in South-East Anatolian Region: Comparison of Characteristics of Classical Papillary and Follicular Variant Thyroid Cancers

True Mixed Medullary Papillary Carcinoma of the Thyroid: a Case Report with Low Blood Calcitonin Levels

ACTH-Secreting Pheochromocytoma with False-Negative ACTH Immunohistochemistry

Carney Stratakis Syndrome in a Patient with SDHD Mutation

Adrenal Haemangioblastoma Presenting as Phaeochromocytoma: A Rare Manifestation of Extraneural Hemangioblastoma

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie